iX Biopharma issues 661,424 new shares after warrant exercise

SGX Filings

Mar 04

iX Biopharma Ltd. announced that it has allotted and issued 661,424 new ordinary shares on Mar, 4 2026 following the exercise of warrants at 0.06 Singapore dollars per share.

The transaction raised the company’s issued share capital to 1,036,957,319 shares from 1,036,295,895.

The new shares, ranking pari passu with existing shares, are expected to begin trading on the Singapore Exchange Securities Trading Limited on or around Mar, 6 2026.

Including this latest exercise, 6,197,874 warrants—representing 10.78% of all warrants previously issued—have now been exercised. The company still has 51,311,605 outstanding warrants, each exercisable at 0.06 Singapore dollars until Jul, 18 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1121152565"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1121152565\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1121152565?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-04 18:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121152565","market":"sg","top_or_hot":-1,"title":"iX Biopharma issues 661,424 new shares after warrant exercise","media":"SGX Filings","content":"\n<p>iX Biopharma Ltd. announced that it has allotted and issued 661,424 new ordinary shares on Mar, 4 2026 following the exercise of warrants at 0.06 Singapore dollars per share.</p>\n<p>The transaction raised the company’s issued share capital to 1,036,957,319 shares from 1,036,295,895.</p>\n<p>The new shares, ranking pari passu with existing shares, are expected to begin trading on the Singapore Exchange Securities Trading Limited on or around Mar, 6 2026.</p>\n<p>Including this latest exercise, 6,197,874 warrants—representing 10.78% of all warrants previously issued—have now been exercised. The company still has 51,311,605 outstanding warrants, each exercisable at 0.06 Singapore dollars until Jul, 18 2026.</p>\n","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>iX Biopharma issues 661,424 new shares after warrant exercise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\niX Biopharma issues 661,424 new shares after warrant exercise\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2026-03-04 18:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n\n<p>iX Biopharma Ltd. announced that it has allotted and issued 661,424 new ordinary shares on Mar, 4 2026 following the exercise of warrants at 0.06 Singapore dollars per share.</p>\n<p>The transaction raised the company’s issued share capital to 1,036,957,319 shares from 1,036,295,895.</p>\n<p>The new shares, ranking pari passu with existing shares, are expected to begin trading on the Singapore Exchange Securities Trading Limited on or around Mar, 6 2026.</p>\n<p>Including this latest exercise, 6,197,874 warrants—representing 10.78% of all warrants previously issued—have now been exercised. The company still has 51,311,605 outstanding warrants, each exercisable at 0.06 Singapore dollars until Jul, 18 2026.</p>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"42C.SI","symbol_name":"IX生物制药","start_time":0,"source_url":"","article_id":"1121152565","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121152565","pubTimestamp":1772619483,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"iX Biopharma Ltd. announced that it has allotted and issued 661,424 new ordinary shares on Mar, 4 2026 following the exercise of warrants at 0.06 Singapore dollars per share. The transaction raised...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"42C.SI":"IX生物制药"},"translate_title":"iX Biopharma在认股权证行使后发行661,424股新股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"42C.SI":1},"content_text":"iX Biopharma Ltd. announced that it has allotted and issued 661,424 new ordinary shares on Mar, 4 2026 following the exercise of warrants at 0.06 Singapore dollars per share.\nThe transaction raised the company’s issued share capital to 1,036,957,319 shares from 1,036,295,895.\nThe new shares, ranking pari passu with existing shares, are expected to begin trading on the Singapore Exchange Securities Trading Limited on or around Mar, 6 2026.\nIncluding this latest exercise, 6,197,874 warrants—representing 10.78% of all warrants previously issued—have now been exercised. The company still has 51,311,605 outstanding warrants, each exercisable at 0.06 Singapore dollars until Jul, 18 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}